QGA
AEON icon

Q Global Advisors’s AEON Biopharma AEON Stock Holding History

Q Global Advisors’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,020
Closed -$713K – 314
2021
Q4 		$713K Buy
+1,020
New +$717K 0.16% 41

Other funds holding AEON

ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Q Global Advisors's AEON Position: Q1 2022 in Review

Q Global Advisors sold out of AEON Biopharma (AEON) in Q1 2022, closing a stake of 1,020 shares — an estimated $713K sold.

Q Global Advisors first reported a position in AEON in Q4 2021 and held it in 1 quarter. The position peaked at $713K in Q4 2021. 71 funds tracked by Wall St. Rank hold AEON as of Q1 2022.

  • Q Global Advisors reported no remaining AEON Biopharma position as of Q1 2022 after selling out during the quarter.
  • Q Global Advisors sold 1,020 AEON Biopharma shares in Q1 2022, an estimated $713K.
  • Q Global Advisors first reported a position in AEON Biopharma in Q4 2021 and held it in 1 quarter.
  • Q Global Advisors's AEON Biopharma position peaked at $713K in Q4 2021.
  • 71 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2022.

Based on Q Global Advisors's 13F filing for Q1 2022, filed 16 May 2022.